Geode Capital Management’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Buy |
91,891
+1,387
| +2% | +$4.38K | ﹤0.01% | 3747 |
|
|
2025
Q1 | $320K | Buy |
90,504
+3,531
| +4% | +$12.5K | ﹤0.01% | 3696 |
|
|
2024
Q4 | $278K | Sell |
86,973
-462
| -0.5% | -$1.47K | ﹤0.01% | 3794 |
|
|
2024
Q3 | $321K | Buy |
87,435
+1,088
| +1% | +$3.99K | ﹤0.01% | 3743 |
|
|
2024
Q2 | $403K | Sell |
86,347
-1,027
| -1% | -$4.8K | ﹤0.01% | 3649 |
|
|
2024
Q1 | $769K | Sell |
87,374
-7,662
| -8% | -$67.4K | ﹤0.01% | 3459 |
|
|
2023
Q4 | $407K | Hold |
95,036
| – | – | ﹤0.01% | 3692 |
|
|
2023
Q3 | $324K | Buy |
95,036
+5,010
| +6% | +$17.1K | ﹤0.01% | 3782 |
|
|
2023
Q2 | $508K | Buy |
90,026
+32,252
| +56% | +$182K | ﹤0.01% | 3633 |
|
|
2023
Q1 | $279K | Hold |
57,774
| – | – | ﹤0.01% | 3897 |
|
|
2022
Q4 | $348K | Sell |
57,774
-135
| -0.2% | -$813 | ﹤0.01% | 3835 |
|
|
2022
Q3 | $276K | Buy |
57,909
+345
| +0.6% | +$1.64K | ﹤0.01% | 4031 |
|
|
2022
Q2 | $328K | Buy |
57,564
+521
| +0.9% | +$2.97K | ﹤0.01% | 3985 |
|
|
2022
Q1 | $407K | Hold |
57,043
| – | – | ﹤0.01% | 4046 |
|
|
2021
Q4 | $455K | Hold |
57,043
| – | – | ﹤0.01% | 4108 |
|
|
2021
Q3 | $637K | Buy |
57,043
+1,564
| +3% | +$17.5K | ﹤0.01% | 3915 |
|
|
2021
Q2 | $809K | Buy |
55,479
+9,649
| +21% | +$141K | ﹤0.01% | 3709 |
|
|
2021
Q1 | $831K | Buy |
+45,830
| New | +$831K | ﹤0.01% | 3631 |
|